Albany Molecular Research, Inc. (AMRI)
326 articles with Albany Molecular Research, Inc. (AMRI)
-
AMRI And NYCNMR Form Collaborative Agreement
1/14/2016
-
AMRI Announces 3-Year Extension Of Insourcing Contract
1/12/2016
-
Eagle Pharma And AMRI Announce Agreement to Jointly Develop, Manufacture And Commercialize Parenteral Drug Products
1/11/2016
-
AMRI Date And Time Change For J.P. Morgan Healthcare Conference Presentation
1/11/2016
-
AMRI Announces First Product Approval Out Of Its Massachusetts Aseptic Fill Finish Site
1/11/2016
-
AMRI And Icagen, Inc. Ink Collaboration Agreement
1/7/2016
-
AMRI CEO To Present At The 34th Annual J.P. Morgan Healthcare Conference
1/4/2016
-
AMRI Acquires Whitehouse Laboratories in $56 Million Deal
12/15/2015
-
AMRI And Multispan Ink Collaboration Agreement
12/10/2015
-
AMRI Launches Its U.S. Integrated Drug Discovery Center
12/7/2015
-
AMRI CEO To Present At Jefferies Autumn 2015 Global Healthcare Conference London
11/13/2015
-
AMRI Announces Third Quarter 2015 Results
11/5/2015
-
Kolltan Pharmaceuticals Inc. To Present Preclinical Data At The 30th Annual Society For Immunotherapy Of Cancer (SITC) Conference And Preclinical Data At The AMRI-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer The
10/30/2015
-
AMRI To Present At Credit Suisse Healthcare Conference
10/29/2015
-
Calithera Biosciences, Inc. Announces Multiple Abstracts Selected For Presentation At The 2015 AMRI-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics
10/27/2015
-
AMRI To Announce Third Quarter 2015 Results
10/20/2015
-
AMRI Updates 2015 Financial Guidance Following Gadea Acquisition
9/15/2015
-
AMRI Promotes Two Company Executives To Key Positions
9/14/2015
-
AMRI Appoints Christopher Conway To Lead AMRI Global Discovery And Development Services Business; Names Vice President Of Discovery Biology And Pharmacology
9/3/2015
-
AMRI To Present At Morgan Stanley Global Healthcare Conference 2015
9/2/2015